The transglutaminase hypothesis for the action of tetanus toxin. 1993

F Facchiano, and F Valtorta, and F Benfenati, and A Luini
Laboratory of Molecular Neurobiology, Mario Negri Institute of Pharmacological Research, Consorzio Mario Negri Sud, S. Maria Imbaro (Chieti), Italy.

Tetanus toxin potently and almost irreversibly inhibits the release of neurotransmitters from nerve terminals. The toxin binds to and activates transglutaminase, a Ca(2+)-dependent enzyme that can form stable crosslinks between substrate proteins. Transglutaminase is present in nerve terminals and recognizes synapsin I, an abundant synaptic vesicle phosphoprotein involved in neurotransmission, as an excellent substrate. The neuroparalytic action of tetanus toxin might be due, at least in part, to the stimulation of synaptic transglutaminase and the consequent crosslinking of synapsin I.

UI MeSH Term Description Entries
D011503 Transglutaminases Transglutaminases catalyze cross-linking of proteins at a GLUTAMINE in one chain with LYSINE in another chain. They include keratinocyte transglutaminase (TGM1 or TGK), tissue transglutaminase (TGM2 or TGC), plasma transglutaminase involved with coagulation (FACTOR XIII and FACTOR XIIIa), hair follicle transglutaminase, and prostate transglutaminase. Although structures differ, they share an active site (YGQCW) and strict CALCIUM dependence. Glutaminyl-Peptide Gamma-Glutamyltransferases,Protein-Glutamine gamma-Glutamyltransferases,Transglutaminase,Gamma-Glutamyltransferases, Glutaminyl-Peptide,Glutaminyl Peptide Gamma Glutamyltransferases,Protein Glutamine gamma Glutamyltransferases,gamma-Glutamyltransferases, Protein-Glutamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001048 Aplysia An opisthobranch mollusk of the order Anaspidea. It is used frequently in studies of nervous system development because of its large identifiable neurons. Aplysiatoxin and its derivatives are not biosynthesized by Aplysia, but acquired by ingestion of Lyngbya (seaweed) species. Aplysias
D013572 Synaptic Vesicles Membrane-bound compartments which contain transmitter molecules. Synaptic vesicles are concentrated at presynaptic terminals. They actively sequester transmitter molecules from the cytoplasm. In at least some synapses, transmitter release occurs by fusion of these vesicles with the presynaptic membrane, followed by exocytosis of their contents. Synaptic Vesicle,Vesicle, Synaptic,Vesicles, Synaptic
D013744 Tetanus Toxin Protein synthesized by CLOSTRIDIUM TETANI as a single chain of ~150 kDa with 35% sequence identity to BOTULINUM TOXIN that is cleaved to a light and a heavy chain that are linked by a single disulfide bond. Tetanolysin is the hemolytic and tetanospasmin is the neurotoxic principle. The toxin causes disruption of the inhibitory mechanisms of the CNS, thus permitting uncontrolled nervous activity, leading to fatal CONVULSIONS. Clostridial Neurotoxin,Clostridium tetani Toxin,Tetanus Toxins,Neurotoxin, Clostridial,Toxin, Clostridium tetani,Toxin, Tetanus,Toxins, Tetanus
D016704 Synapsins A family of synaptic vesicle-associated proteins involved in the short-term regulation of NEUROTRANSMITTER release. Synapsin I, the predominant member of this family, links SYNAPTIC VESICLES to ACTIN FILAMENTS in the presynaptic nerve terminal. These interactions are modulated by the reversible PHOSPHORYLATION of synapsin I through various signal transduction pathways. The protein is also a substrate for cAMP- and CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES. It is believed that these functional properties are also shared by synapsin II. Synapsin,Synapsin I,Synapsin II,Synapsin III
D018377 Neurotransmitter Agents Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. Nerve Transmitter Substance,Neurohormone,Neurohumor,Neurotransmitter Agent,Nerve Transmitter Substances,Neurohormones,Neurohumors,Neuromodulator,Neuromodulators,Neuroregulator,Neuroregulators,Neurotransmitter,Neurotransmitters,Substances, Nerve Transmitter,Transmitter Substances, Nerve,Substance, Nerve Transmitter,Transmitter Substance, Nerve

Related Publications

F Facchiano, and F Valtorta, and F Benfenati, and A Luini
September 1994, The Journal of biological chemistry,
F Facchiano, and F Valtorta, and F Benfenati, and A Luini
April 1957, Proceedings of the staff meetings. Mayo Clinic,
F Facchiano, and F Valtorta, and F Benfenati, and A Luini
March 1994, Annals of the New York Academy of Sciences,
F Facchiano, and F Valtorta, and F Benfenati, and A Luini
August 1939, The Journal of physiology,
F Facchiano, and F Valtorta, and F Benfenati, and A Luini
June 1950, La Semana medica,
F Facchiano, and F Valtorta, and F Benfenati, and A Luini
June 1970, The Journal of pharmacy and pharmacology,
F Facchiano, and F Valtorta, and F Benfenati, and A Luini
June 1961, Journal of general microbiology,
F Facchiano, and F Valtorta, and F Benfenati, and A Luini
January 1955, Nature,
F Facchiano, and F Valtorta, and F Benfenati, and A Luini
November 1965, Indian journal of medical sciences,
F Facchiano, and F Valtorta, and F Benfenati, and A Luini
January 1972, Bollettino dell'Istituto sieroterapico milanese,
Copied contents to your clipboard!